28. Kelsh MA, Alexander DD, Mink PJ, Mandel JH. Occupational trichloroethylene exposure and kidney cancer: a meta-analysis. Epidemiology [Internet]. 2010 Jan;21(1):95–102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20010212
29. Theis RP, Dolwick Grieb SM, Burr D, Siddiqui T, Asal NR. Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study. BMC Cancer [Internet]. 2008 Dec 24;8:387. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19108730
30. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J cancer [Internet]. 2005 Mar 10;114(1):101–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15523697
31. Hidayat K, Du X, Zou S-Y, Shi B-M. Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens [Internet]. 2017;35(7):1333–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28157813
32. Macleod LC, Hotaling JM, Wright JL, Davenport MT, Gore JL, Harper J, et al. Risk Factors for Renal Cell Carcinoma in the VITAL Study. J Urol [Internet]. 2013 Nov;190(5):1657–61. Available from: http://www.jurology.com/doi/10.1016/j.juro.2013.04.130
33. Liu X, Sun Q, Hou H, Zhu K, Wang Q, Liu H, et al. The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline. Medicine (Baltimore) [Internet]. 2018 Nov;97(44):e12860. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30383638
34. Choueiri TK, Je Y, Cho E. Analgesic use and the risk of kidney cancer: A meta-analysis of epidemiologic studies. Int J Cancer [Internet]. 2014 Jan 15;134(2):384–96. Available from: http://doi.wiley.com/10.1002/ijc.28093
35. Umbas R, Safriadi F, Mochtar CA, Djatisoesanto W, Hamid ARAH. Urologic cancer in Indonesia. Jpn J Clin Oncol. 2015;45(8):708–12.
36. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU Guidelines on Renal Cell Carcinoma: 2014 Update. Eur Urol [Internet]. 2015 May;67(5):913–24. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0302283815000196
37. Arora HC, Fascelli M, Zhang JJH, Isharwal S, Campbell SC. Kidney, Ureteral, and Bladder Cancer: A Primer for the Internist. Med Clin North Am. 2018;102(2):231–49.
38. Herts BR, Silverman SG, Hindman NM, Uzzo RG, Hartman RP, Israel GM, et al. Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol [Internet]. 2018;15(2):264–73. Available from: https://doi.org/10.1016/j.jacr.2017.04.028
39. Israel GM, Silverman SG. The Incidental Renal Mass. Radiol Clin North Am [Internet]. 2011;49(2):369–83. Available from: http://dx.doi.org/10.1016/j.rcl.2010.10.007
40. Chandrankunnel J, Cunha BA, Petelin A, Katz D. Fever of unknown origin (FUO) and a renal mass: Renal cell carcinoma, renal tuberculosis, renal malakoplakia, or xanthogranulomatous pyelonephritis? Hear Lung [Internet]. 2012 Nov;41(6):606–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0147956312001379
41. Psutka SP, Leibovich BC. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma. Ther Adv Urol [Internet]. 2015 Aug;7(4):216–29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26445601
42. Tamburrini A, Majorino A, Duggan S, Jogai S, Alzetani A. A record-breaking lung metastasis from renal cell carcinoma 37 years after nephrectomy. J Surg Case Reports [Internet]. 2017 Oct 1;2017(10). Available from: https://academic.oup.com/jscr/article/doi/10.1093/jscr/rjx205/4559817
43. Umer M, Mohib Y, Atif M, Nazim M. Skeletal metastasis in renal cell carcinoma: A review. Ann Med Surg [Internet]. 2018;27(October 2017):9–16. Available from: https://doi.org/10.1016/j.amsu.2018.01.002
44. Pepper K, Jaowattana U, Starsiak MD, Halkar R, Hornaman K, Wang W, et al. Renal cell carcinoma presenting with paraneoplastic hypercalcemic coma: a case report and review of the literature. J Gen Intern Med [Internet]. 2007 Jul;22(7):1042–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17443359
45. Hegemann M, Kroeger N, Stenzl A, Bedke J. Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma. World J Urol [Internet]. 2018;36(6):849–54. Available from: https://doi.org/10.1007/s00345-018-2215-9
46. Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, et al. Brain metastasis from renal cell carcinoma: Presentation, recurrence, and survival. Cancer. 2008;113(7):1641–8.
47. Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, et al. Distribution of metastatic sites in renal cell carcinoma: A population-based analysis. Ann Oncol. 2012;23(4):973–80.
48. Blecher G, Challacombe B. Renal cancer. Surg [Internet]. 2016 Oct 21;34(10):512–6. Available from: http://dx.doi.org/10.1016/j.mpsur.2016.07.003
49. Agrawal A, Sahni S, Iftikhar A, Talwar A. Pulmonary manifestations of renal cell carcinoma. Respir Med [Internet]. 2015;109(12):1505–8. Available from: http://dx.doi.org/10.1016/j.rmed.2015.10.002
50. Langdon J, Way A, Heaton S, Bernard J, Molloy S. The management of spinal metastases from renal cell carcinoma. Ann R Coll Surg Engl [Internet]. 2009 Nov;91(8):649–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19686617
51. Ozkiriş M, Kubilay U, Sezen OS. Cervical lymph node metastasis in renal cell carcinoma. J Oral Maxillofac Pathol [Internet]. 2011 May;15(2):211–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22529583
52. Nini A, Larcher A, Cianflone F, Trevisani F, Terrone C, Volpe A, et al. The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma. Front Surg [Internet]. 2018 Mar 28;5. Available from: http://journal.frontiersin.org/article/10.3389/fsurg.2018.00026/full
53. Mittal M, Sureka B. Solid renal masses in adults. Indian J Radiol Imaging [Internet]. 2016;26(4):429. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28104933
54. Kurban LAS, Vosough A, Jacob P, Prasad D, Lam T, Scott N, et al. Pathological nature of renal tumors - does size matter? Urol Ann [Internet]. 9(4):330–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29118533
55. Köhle O, Abt D, Rothermundt C, Öhlschlegel C, Brugnolaro C, Schmid H-P. Soft tissue sarcomas of the kidney. Rare Tumors [Internet]. 2015 Feb 11;7(1):5635. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25918607
56. Shuch B, Bratslavsky G, Linehan WM, Srinivasan R. Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist [Internet]. 2012;17(1):46–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22234634
57. Ganeshan D, Iyer R, Devine C, Bhosale P, Paulson E. Imaging of Primary and Secondary Renal Lymphoma. Am J Roentgenol [Internet]. 2013 Nov;201(5):W712–9. Available from: http://www.ajronline.org/doi/10.2214/AJR.13.10669
58. Karmali RJ, Suami H, Wood CG, Karam JA. Lymphatic drainage in renal cell carcinoma: Back to the basics. BJU Int. 2014;114(6):806–17.
59. Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, Matin SF, et al. Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int [Internet]. 2016 May;117(5):775–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26053895
60. Freire M, Remer EM. Clinical and Radiologic Features of Cystic Renal Masses. Am J Roentgenol [Internet]. 2009 May;192(5):1367–72. Available from: http://www.ajronline.org/doi/10.2214/AJR.08.1468
61. Sankineni S, Brown A, Phil M, Cieciera M, Choyke PL, Turkbey B. Imaging of renal cell carcinoma. Urol Oncol Semin Orig Investig [Internet]. 2015;1–9. Available from: http://dx.doi.org/10.1016/j.urolonc.2015.05.020
62. Ishigami K, Pakalniskis MG, Leite L V., Lee DK, Holanda DG, Rajput M. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography. Clin Imaging [Internet]. 2015 Jan;39(1):76–84. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0899707114002381
63. Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, et al. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch [Internet]. 2010 Apr;456(4):355–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20300772
66. Ikatan Ahli Urologi Indonesia. Panduan Penanganan Kanker Ginjal. Jakarta; 2012.
67. Mekhail TM, Abou-Jawde RM, Boumerhi G, Malhi S, Wood L, Elson P, et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol [Internet]. 2005 Feb 1;23(4):832–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15681528
69. Kay FU, Pedrosa I. Imaging of Solid Renal Masses. Urol Clin North Am [Internet]. 2018;45(3):311–30. Available from: https://doi.org/10.1016/j.ucl.2018.03.013